The effects of inhaled NO on plasma vasoactive factor and CTnI level in rabbits with acute massive pulmonary embolism
Acta cir. bras; 33 (7), 2018
Publication year: 2018
Abstract Purpose:
To investigate changes in the plasma concentrations of cardiac troponin I (CTnI), thromboxane A2 (TXA2), prostaglandin I2 (PGI2) and endothelin-1 (ET-1) in rabbits with massive pulmonary embolism (AMPE) and the impact of nitric oxide inhalation (NOI) on these indices.Methods:
A total of 30 Japanese rabbits were used to construct an MPE model and were divided into 3 groups equally (n=10), including an EXP group (undergoing modeling alone), an NOI group (receiving NOI 2 h post-modeling) and a CON group (receiving intravenous physiological saline).Results:
In the model group, plasma concentration of CTnI peaked at 16 h following modeling (0.46±0.10 µg/ml) and significantly decreased following NOI. Plasma levels of TXB2, PGI2 and ET-1 peaked at 12, 16 and 8 h following modeling, respectively, and significantly decreased at different time points (0, 2, 4, 8, 12, 16, 20 and 24 h) following NOI. A significant correlation was observed between the peak plasma CTnI concentration and peak TXB2, 6-keto prostaglandin F1α and ET-1 concentrations in the model and NOI groups.Conclusion:
Increases in plasma TXA2, PGI2 and ET-1 levels causes myocardial damage in a rabbit model of AMPE; however, NOI effectively down regulates the plasma concentration of these molecules to produce a myocardial-protective effect.
Enfermedad Aguda, Administración por Inhalación, Broncodilatadores/farmacología, Regulación hacia Abajo, Endotelina-1/sangre, Ensayo de Inmunoadsorción Enzimática, Epoprostenol/sangre, Óxido Nítrico/farmacología, Embolia Pulmonar/sangre, Embolia Pulmonar/tratamiento farmacológico, Embolia Pulmonar/patología, Distribución Aleatoria, Valores de Referencia, Reproducibilidad de los Resultados, Tromboxano A2/sangre, Factores de Tiempo, Resultado del Tratamiento, Troponina I/sangre